Other/unspecified cytomegaloviral diseases

CMV_NOS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B25.8, B25.8+G05.1, B25.9 Hospital discharge: ICD-9 — 0785X Hospital discharge: ICD-8 — 0795 Cause of death: ICD-10 — B25.8, B25.8+G05.1, B25.9 Cause of death: ICD-9 — 0785X Cause of death: ICD-8 — 0795 2 out of 7 registries used, show all original rules.	649
4. Check minimum number of events None	649
5. Include endpoints None	649
6. Filter based on genotype QC (FinnGen only)	649

Control definitions (FinnGen only)

Control exclude: IBD_CMV

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	CMV_NOS
CONTROL_EXCLUDE	IBD_CMV
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B25[8-9]
HD_ICD_9	0785X
HD_ICD_8	0795
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B25[8-9]
COD_ICD_9	0785X
COD_ICD_8	0795
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other/unspecified cytomegaloviral diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3534	1602	1906
Only index persons	2987	1369	1618
Unadjusted period prevalence (%)
Whole population	0.05	0.05	0.05
Only index persons	0.06	0.05	0.06
Median age at first event (years)
Whole population	51.68	52.05	51.36
Only index persons	52.44	52.68	52.24

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	649	318	331
Unadjusted period prevalence (%)	0.13	0.11	0.15
Median age at first event (years)	53.86	51.53	56.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
592: Matched controls
5916

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

+∞

323.0

334

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

+∞

323.0

296

127

Kela drug reimbursment

Transplant complication

138.6

300.3

305

L04AA06

ATC

mycophenolic acid; systemic

96.7

235.1

252

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

29.5

185.9

262

155

Z94.0

ICD-10 Finland

Kidney transplant status

92.9

171.7

186

L04AD01

ATC

ciclosporin; systemic

62.6

168.9

195

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

22.1

158.6

246

184

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

99.1

148.6

160

H02AB04

ATC

methylprednisolone; systemic

12.6

146.4

312

482

R50.9

ICD-10 Finland

Fever, unspecified

12.6

140.7

294

429

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

43.6

136.8

170

TK800

NOMESCO Finland

Hemodialysis

43.5

132.7

165

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

49.3

132.3

160

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

69.4

129.5

147

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

10.4

119.4

275

454

A11CC03

ATC

alfacalcidol; systemic

36.2

112.6

146

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

23.4

111.0

164

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

88.8

104.8

115

C03CA01

ATC

furosemide; systemic

7.6

102.8

310

749

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

29.5

98.0

134

A49.9

ICD-10 Finland

Bacterial infection, unspecified

10.9

96.8

206

277

B03XA02

ATC

darbepoetin alfa; parenteral

39.0

96.1

122

A12AA04

ATC

calcium carbonate; oral

45.2

95.2

117

XW000

NOMESCO Finland

Bone marrow biopsy

20.2

94.8

147

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.3

91.2

341

1052

Z49.1

ICD-10 Finland

Extracorporeal dialysis

48.0

88.2

107

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

13.3

84.8

158

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

16.6

84.4

141

109

137

Kela drug reimbursment

Uraemia requiring dialysis

62.6

82.2

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

72.3

81.4

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

49.4

79.6

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.3

78.4

408

1735

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

70.6

74.9

M04AA01

ATC

allopurinol; systemic

8.1

74.1

187

318

ZX120

NOMESCO Finland

Intravenous

8.5

73.8

180

290

N18.8

ICD-10 Finland

Other chronic renal failure

23.7

72.9

106

WW500

NOMESCO Finland

Blood transfusion

17.3

72.3

118

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.5

71.7

222

502

A05AA02

ATC

ursodeoxycholic acid; oral

29.2

70.4

B05DA

ATC

Isotonic solutions

69.8

69.5

R4110

NOMESCO Finland

Physiotherapy

5.1

69.2

296

972

L04AA01

ATC

[U] ciclosporin; systemic

31.8

69.1

V03AE01

ATC

polystyrene sulfonate; oral

53.4

66.5

TPX10

NOMESCO Finland

Implantation of vascular injection port

21.2

66.5

100

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

35.2

65.6

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

41.8

64.2

L03AA02

ATC

filgrastim; parenteral

20.1

61.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

5.0

60.2

240

706

N18.0

ICD-10 Finland

End-stage renal disease

35.2

59.5

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

29.2

58.2

Z49.2

ICD-10 Finland

Other dialysis

51.9

57.8

ZXD05

NOMESCO Finland

Urgent procedure

4.3

57.4

302

1156

L04AX01

ATC

azathioprine; systemic

10.5

56.4

116

134

WW200

NOMESCO Finland

Immunization

14.8

56.3

ZXE20

NOMESCO Finland

More than three and less than five hours

5.7

55.5

185

437

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

15.8

54.9

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

125.8

53.8

B05DB

ATC

Hypertonic solutions

54.0

53.2

J05AB11

ATC

valaciclovir; oral

5.7

52.8

175

408

WX408

NOMESCO Finland

General anesthesy, balanced

4.0

51.6

281

1082

C08CA01

ATC

amlodipine; oral

3.9

51.3

300

1227

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.7

50.6

142

266

TPH04

NOMESCO Finland

Cathetrisation of vein

4.4

49.3

225

729

J01MA12

ATC

levofloxacin; systemic

4.6

48.5

201

591

A41.9

ICD-10 Finland

Sepsis, unspecified

14.9

48.0

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.3

47.7

221

723

Z49.0

ICD-10 Finland

Preparatory care for dialysis

31.9

47.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

11.1

47.6

Z2446

NOMESCO Finland

Social worker

7.2

46.4

122

207

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

41.8

45.9

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

79.3

45.8

ZX108

NOMESCO Finland

Inhalation

44.0

45.6

H02AB09

ATC

hydrocortisone; systemic

17.8

44.8

B03XA01

ATC

erythropoietin; parenteral

52.7

44.7

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

9.1

43.2

121

196

Kela drug reimbursment

Paricalcitol and cinacalcet

74.3

42.7

TGC00

NOMESCO Finland

Bronchial lavation

16.1

41.9

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

9.1

41.8

117

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.4

40.8

175

519

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

7.0

40.8

108

183

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.5

40.6

251

1018

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

6.8

39.8

107

185

V03AE02

ATC

sevelamer; oral

34.7

39.5

N17.9

ICD-10 Finland

Acute renal failure, unspecified

10.8

39.3

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

43.4

39.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

4.1

38.9

181

576

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

60.6

38.9

JN4BD

NOMESCO Finland

Extensive body CT

5.2

38.1

130

302

ZXE00

NOMESCO Finland

One hour or less

3.1

37.1

316

1593

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

11.7

36.9

205

Kela drug reimbursment

Chronic hypertension

3.4

36.3

223

883

JN4AD

NOMESCO Finland

Body CT examination

6.1

35.4

104

201

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

14.4

34.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

10.4

33.8

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.0

33.7

100

195

5AB14

NOMESCO Finland

95.6

33.1

Z94.4

ICD-10 Finland

Liver transplant status

57.8

32.7

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

34.6

32.6

ZXE10

NOMESCO Finland

More than one and less than three hours

2.9

32.4

289

1458

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

5.6

32.4

101

209

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.0

32.3

113

266

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

76.3

32.2

KA1AE

NOMESCO Finland

Kidney ultrasound examination

11.8

32.0

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

22.6

31.8

ZXA00

NOMESCO Finland

Right side

3.1

31.6

223

958

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

30.0

31.5

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

329.2

31.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.8

30.7

319

1749

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

40.5

30.6

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.0

30.6

138

417

J01MA14

ATC

moxifloxacin; systemic

5.3

30.3

100

220

H05BX01

ATC

cinacalcet; oral

71.8

30.2

H02AB06

ATC

prednisolone; systemic

2.7

30.0

329

1855

D64.9

ICD-10 Finland

Anaemia, unspecified

5.3

29.7

211

J05AB01

ATC

aciclovir; systemic

3.3

29.6

182

703

Z3226

NOMESCO Finland

Physiotherapist

3.4

29.4

174

653

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

29.7

29.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

6.8

29.2

128

C02AC05

ATC

moxonidine; oral

8.4

29.2

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

21.0

29.1

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

157.6

28.9

GD1AD

NOMESCO Finland

Thorax CT examination

7.9

28.8

N02AX02

ATC

tramadol; systemic, rectal

2.7

28.7

311

1722

A02BC02

ATC

pantoprazole; systemic

2.8

28.4

430

2894

B99

ICD-10 Finland

Other and unspecified infectious diseases

16.0

28.3

WX002

NOMESCO Finland

Sedation and analgesia

3.2

28.2

179

703

UJF32

NOMESCO Finland

Coloscopy

3.0

28.1

209

917

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

294.6

28.0

TK820

NOMESCO Finland

Peritoneal dialysis

37.1

27.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

6.0

27.1

149

J01MA02

ATC

ciprofloxacin; systemic

2.6

26.6

282

1522

A04AA01

ATC

ondansetron; systemic, rectal

5.9

26.5

149

A07AA02

ATC

nystatin; oral

5.7

26.5

158

N02AA05

ATC

oxycodone; systemic

3.8

26.4

123

378

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

5.7

26.3

155

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.1

26.2

112

319

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.9

26.2

211

RS220

NOMESCO Finland

13.8

26.1

D70.82

ICD-10 Finland

Drug-induced neutropenia

13.8

26.1

Z3231

NOMESCO Finland

Registered nurse

2.8

25.9

224

1067

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

14.9

25.7

C08CA02

ATC

felodipine; oral

4.8

25.6

216

WX892

NOMESCO Finland

Monitored bed care

4.6

25.4

237

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

40.8

25.1

TPH07

NOMESCO Finland

Cathetrisation of artery

3.9

24.7

110

324

D70.89

ICD-10 Finland

Neutropenic splenomegaly

19.6

24.7

C07AG02

ATC

carvedilol; oral

5.7

24.4

142

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

12.4

24.4

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

7.7

24.0

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.5

24.0

258

1378

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

28.1

23.8

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

5.4

23.6

152

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.8

23.6

109

330

C07AB07

ATC

bisoprolol; oral

2.5

23.6

296

1712

H26.3

ICD-10 Finland

Drug-induced cataract

35.0

23.5

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

48.8

23.5

C07AB02

ATC

metoprolol; systemic

3.1

23.4

151

589

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

21.1

23.3

321

Kela drug reimbursment

Paricalcitol and cinacalcet

56.4

23.2

A02BC01

ATC

omeprazole; systemic

2.7

23.2

209

1008

JN3AD

NOMESCO Finland

Abdominal CT examination

4.4

23.1

228

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

7.4

23.1

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

6.6

22.8

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

8.6

22.7

C09AA02

ATC

enalapril; systemic

3.0

22.3

150

602

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

15.2

21.9

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

227.9

21.7

V03AE03

ATC

lanthanum carbonate; oral

45.1

21.6

J01FF01

ATC

clindamycin; systemic

2.6

21.6

203

993

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

10.0

21.4

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

13.5

21.4

JJC00

NOMESCO Finland

Allogenic transplantation of liver

52.0

21.3

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

7.7

21.3

H3603, E103

ICD-10 Finland

17.4

21.2

KBV00

NOMESCO Finland

Insertion of stent into ureter

18.7

21.1

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

14.8

21.1

ZXA05

NOMESCO Finland

Left side

2.7

21.0

181

842

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.0

20.8

256

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.7

20.7

164

725

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

5.5

20.7

125

Z2221

NOMESCO Finland

Medical doctor

2.5

20.5

209

1064

C90.0

ICD-10 Finland

Multiple myeloma

21.7

20.1

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.7

20.0

282

121

Kela drug reimbursment

Severe hypofunction of sexual glands

10.6

19.6

B02.9

ICD-10 Finland

Zoster without complication

5.2

19.6

133

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

16.3

19.5

ZXD10

NOMESCO Finland

Scheduled procedure

2.3

19.4

256

1473

B01AB10

ATC

tinzaparin; parenteral

4.3

19.4

192

WX872

NOMESCO Finland

Intensive care

4.7

19.4

158

H43.1

ICD-10 Finland

Vitreous haemorrhage

10.3

19.4

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

5.0

19.3

140

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

23.5

19.2

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

9.4

18.9

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

39.8

18.7

WW300

NOMESCO Finland

Transfer of autologic stem cells

39.8

18.7

C02CA01

ATC

prazosin; oral

15.0

18.3

A10AA01

ATC

7.8

18.3

B01AB05

ATC

enoxaparin; parenteral

2.4

18.2

205

1084

N17.8

ICD-10 Finland

Other acute renal failure

16.0

18.1

J02AC03

ATC

voriconazole; systemic

34.1

18.1

TK810

NOMESCO Finland

Hemofiltration

14.3

17.9

212

Kela drug reimbursment

Gout

10.9

17.9

Z94.1

ICD-10 Finland

Heart transplant status

38.0

17.7

K65.0

ICD-10 Finland

Acute peritonitis

16.2

17.6

SPAT1255

SPAT

Intravenous administration of medicine

4.5

17.6

154

TPX15

NOMESCO Finland

Removal of vascular injection port

29.8

17.5

N19

ICD-10 Finland

Unspecified kidney failure

7.9

17.5

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

43.4

17.4

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

9.5

17.1

5BA08

NOMESCO Finland

51.6

17.1

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

6.6

17.0

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.1

16.9

186

Z01.8

ICD-10 Finland

Other specified special examinations

2.5

16.9

156

741

AA1AD

NOMESCO Finland

CT of head and brain

2.4

16.8

166

815

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

5.4

16.8

101

WX882

NOMESCO Finland

High dependency care

6.9

16.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

16.7

125

525

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

16.9

16.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.1

16.7

340

2323

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

92.7

16.6

Z94.2

ICD-10 Finland

Lung transplant status

92.7

16.6

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

28.5

16.6

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.2

16.6

107

JAL10

NOMESCO Finland

Laparotomy and removal of foreign body

174.6

16.6

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

20.8

16.5

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

23.8

16.5

K51.5

ICD-10 Finland

Left sided colitis

6.3

16.5

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.7

16.4

127

546

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

16.3

117

479

R4190

NOMESCO Finland

Nutritional therapy

5.1

16.2

110

N05CF01

ATC

zopiclone; oral

2.2

16.1

209

1166

A10AA02

ATC

6.5

16.1

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

61.7

15.8

WZC30

NOMESCO Finland

Teaching

2.8

15.8

111

448

ZXE40

NOMESCO Finland

More than seven and less than nine hours

7.5

15.8

WX402

NOMESCO Finland

General anaesthesia

2.6

15.7

133

599

ZX112

NOMESCO Finland

Subcutaneous

8.9

15.7

M05BA04

ATC

alendronic acid; oral

4.0

15.6

178

B34.9

ICD-10 Finland

Viral infection, unspecified

6.6

15.6

L03AA13

ATC

pegfilgrastim; parenteral

5.9

15.6

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

4.1

15.5

164

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

7.6

15.5

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.9

15.5

185

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

39.2

15.5

A07AA09

ATC

vancomycin; oral

10.8

15.4

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

9.6

15.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

7.4

15.3

6BA02

NOMESCO Finland

29.5

15.3

C08CA13

ATC

lercanidipine; oral

3.0

15.2

356

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

46.2

15.1

A41.8

ICD-10 Finland

Other specified sepsis

9.8

15.1

M01AE01

ATC

ibuprofen; systemic, rectal

0.5

15.0

387

4749

UJF30

NOMESCO Finland

Ileoscopy through colon

3.2

14.9

293

U14

ICPC

Kidney symptom/complaint

11.7

14.9

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.8

14.9

L04AX04

ATC

lenalidomide; oral

58.2

14.8

153

Kela drug reimbursment

Lenalidomid

58.2

14.8

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

58.2

14.8

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

5.6

14.8

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

8.1

14.8

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

+∞

14.6

5AD01

NOMESCO Finland

+∞

14.6

L04AA05

ATC

[U] tacrolimus; systemic

82.1

14.6

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

153.5

14.5

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

37.0

14.5

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

13.0

14.5

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

17.5

14.4

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

5.4

14.2

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

43.6

14.2

RD210

NOMESCO Finland

7.8

14.1

SPAT1262

SPAT

Handing over of treatment supplies

2.4

14.0

133

634

H02AB02

ATC

dexamethasone; systemic

3.2

14.0

275

A06AD11

ATC

lactulose; oral

2.9

14.0

362

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.4

13.9

225

K65.9

ICD-10 Finland

Peritonitis, unspecified

54.7

13.9

ZX197

NOMESCO Finland

54.7

13.9

KBV10

NOMESCO Finland

Removal of stent from ureter

20.6

13.9

R11

ICD-10 Finland

Nausea and vomiting

3.4

13.8

215

XCK10

NOMESCO Finland

Photography of fundus of eye

3.1

13.8

279

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.8

13.8

364

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

76.9

13.6

A10AE05

ATC

insulin detemir; parenteral

4.1

13.6

142

M10.9

ICD-10 Finland

Gout, unspecified

3.8

13.6

168

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

18.8

13.4

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

18.8

13.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

8.4

13.4

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

8.4

13.4

J01DB01

ATC

cefalexin; oral

2.2

13.4

494

4095

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

41.0

13.2

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.0

13.1

304

ZXA10

NOMESCO Finland

Bilateral

2.4

13.1

122

573

ED1AA

NOMESCO Finland

Mandipular X-ray examination

17.2

13.1

WX110

NOMESCO Finland

Local anesthesy

2.0

13.0

422

3293

3AC01

NOMESCO Finland

11.9

12.9

1CX01

NOMESCO Finland

51.1

12.9

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

51.1

12.9

JJ5AT

NOMESCO Finland

51.1

12.9

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

9.3

12.8

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10.8

12.8

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

14.5

12.8

B01AB04

ATC

dalteparin; parenteral

4.4

12.8

110

HA1AA

NOMESCO Finland

X-ray mammography

3.7

12.8

161

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.8

12.7

151

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

32.8

12.6

J96.0

ICD-10 Finland

Acute respiratory failure

17.8

12.6

B01AA03

ATC

warfarin; systemic

2.5

12.6

112

514

A07EC02

ATC

mesalazine; oral, rectal

3.7

12.6

158

Z51.5

ICD-10 Finland

Palliative care

4.5

12.5

103

SAA04

NOMESCO Finland

Special inverstigation of mouth

3.5

12.5

180

WW409

NOMESCO Finland

Other aferesis

24.9

12.5

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

132.6

12.5

C08CA05

ATC

nifedipine; systemic

3.9

12.4

144

TDM10

NOMESCO Finland

Puncture of maxillary antrum

4.9

12.4

NHQ40

NOMESCO Finland

Amputation of toe

9.3

12.3

A03

ICPC

Fever

2.4

12.3

120

577

Z96.1

ICD-10 Finland

Presence of intraocular lens

3.0

12.3

276

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.9

12.3

140

RJ420

NOMESCO Finland

38.4

12.3

E87.5

ICD-10 Finland

Hyperkalaemia

12.8

12.2

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

18.5

12.1

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

12.1

133

677

A46

ICD-10 Finland

Erysipelas

2.6

12.1

414

C10AA03

ATC

pravastatin; oral

3.8

12.0

148

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.1

11.9

J01CA04

ATC

amoxicillin; systemic

2.1

11.9

487

4067

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.7

11.9

155

S97

ICPC

Chronic ulcer skin

4.1

11.8

119

SAA03

NOMESCO Finland

Extended examination of mouth

1.9

11.8

253

1680

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

4.8

11.8

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.9

11.8

135

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

7.9

11.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

11.7

224

1423

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

11.7

144

769

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

12.9

11.7

H05BX02

ATC

paricalcitol; systemic

66.2

11.6

B59

ICD-10 Finland

Pneumocystosis

66.2

11.6

A10AE04

ATC

insulin glargine; parenteral

2.9

11.6

269

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.9

11.5

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.3

11.5

198

EBA10

NOMESCO Finland

Surgical removal of tooth

2.5

11.5

416

D59.1

ICD-10 Finland

Other autoimmune haemolytic anaemias

122.2

11.5

A07EA06

ATC

budesonide; oral, local oral

4.9

11.4

XF600

NOMESCO Finland

Bloodpressure measurement

3.5

11.3

161

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

11.3

246

Z99.2

ICD-10 Finland

Dependence on renal dialysis

35.8

11.3

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

35.8

11.3

B07.9

ICD-10 Finland

Verruca simplex

4.5

11.2

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.1

11.2

219

RJ410

NOMESCO Finland

25.6

11.2

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

25.6

11.2

WW400

NOMESCO Finland

Plasmaferesis

25.6

11.2

J02AC01

ATC

fluconazole; systemic

1.9

11.1

237

1559

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.9

11.0

122

H25.1

ICD-10 Finland

Senile nuclear cataract

2.3

11.0

114

562

N30.0

ICD-10 Finland

Acute cystitis

2.6

11.0

362

WW402

NOMESCO Finland

Leucoferesis

44.2

11.0

XPX08

NOMESCO Finland

Intraoperative flow measurement

12.2

10.9

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

15.9

10.9

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

10.8

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.9

10.8

119

ZX121

NOMESCO Finland

Central venous catheter

18.2

10.8

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.2

10.8

128

670

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

10.7

393

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

21.9

10.7

GDG10

NOMESCO Finland

Bilateral transplantation of lung

61.1

10.7

187

Kela drug reimbursment

MPA

61.1

10.7

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

61.1

10.7

Z3229

NOMESCO Finland

Other healthcare associate professional

2.9

10.6

246

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

11.5

10.6

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

11.5

10.6

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

11.5

10.6

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

3.6

10.6

137

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.8

10.6

265

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.2

10.5

188

I50.9

ICD-10 Finland

Heart failure, unspecified

2.8

10.5

258

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

111.9

10.4

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

111.9

10.4

0785X

ICD-9 Finland

Other diseases due to viruses and Chlamydiae, Cytomegaloviral disease[VIROSIS ALIA CYTOMEGALICA]

+∞

10.4

J02AC04

ATC

posaconazole; systemic

+∞

10.4

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.5

10.4

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.5

10.4

145

YNB10

NOMESCO Finland

Collection of stem cells for transplant

33.1

10.4

E83.50

ICD-10 Finland

Hypercalcemia

9.8

10.3

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.2

10.3

GD2SN

NOMESCO Finland

Lung ventilation SPECT

19.2

10.3

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

19.2

10.3

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

7.7

10.3

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.4

10.3

ZX090

NOMESCO Finland

Other technic of radiotherapy

6.1

10.2

R31

ICD-10 Finland

Unspecified haematuria

2.8

10.1

253

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

7.4

10.1

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.7

10.0

122

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.1

10.0

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

40.8

10.0

C95.0

ICD-10 Finland

Acute leukaemia of unspecified cell type

40.8

10.0

A04AA02

ATC

granisetron; systemic, transdermal

3.4

10.0

150

A28

ICPC

Limited function/disability NOS

2.5

9.9

341

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

17.1

9.9

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

17.1

9.9

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

17.1

9.9

K83.0

ICD-10 Finland

Cholangitis

8.3

9.9

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

3.4

9.9

151

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.4

9.9

151

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.1

9.9

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

20.4

9.8

D64.8

ICD-10 Finland

Other specified anaemias

10.9

9.8

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

6.7

9.8

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.9

9.8

109

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.6

9.8

TQW99

NOMESCO Finland

Other minor procedure on skin

3.6

9.8

125

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

13.7

9.7

WX610

NOMESCO Finland

Patient controlled analgesia

13.7

9.7

RJ411

NOMESCO Finland

13.7

9.7

329

Kela drug reimbursment

Lenalidomide

55.9

9.7

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

9.7

111

571

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

8.6

9.6

TAB00

NOMESCO Finland

Lumbar puncture

3.5

9.5

128

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.9

9.5

102

GD1LA

NOMESCO Finland

7.7

9.5

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

101.5

9.4

GD1UN

NOMESCO Finland

Lung circulation SPECT

17.9

9.4

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

17.9

9.4

JN4CD

NOMESCO Finland

Very extensive body CT

4.3

9.4

ZX100

NOMESCO Finland

Oral

8.2

9.4

B73

ICPC

Leukaemia

+∞

9.4

V03AG01

ATC

sodium cellulose phosphate; systemic

+∞

9.4

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

22.1

9.4

N03AX16

ATC

pregabalin; oral

2.0

9.3

146

850

TKC20

NOMESCO Finland

Catheterisation of bladder

3.2

9.3

164

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.1

9.3

179

R06.0

ICD-10 Finland

Dyspnoea

2.0

9.2

137

784

XG410

NOMESCO Finland

Flow-volume spirometry

4.0

9.2

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

9.1

115

614

WX204

NOMESCO Finland

Axillary plexus blockaced

4.4

9.1

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

11.7

9.1

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

15.9

9.1

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.6

9.1

277

RJ120

NOMESCO Finland

37.3

9.0

XW4XT

NOMESCO Finland

Biopsy of other inner organ with radiological guidance guidance

37.3

9.0

D46.7

ICD-10 Finland

Other myelodysplastic syndromes

37.3

9.0

XX4BW

NOMESCO Finland

37.3

9.0

A12BA01

ATC

potassium chloride; oral

4.8

9.0

WX199

NOMESCO Finland

Other local analgesia

5.4

9.0

H36.00

ICD-10 Finland

Diabetic background retinopathy

7.6

9.0

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.2

8.9

152

PJA10

NOMESCO Finland

Exploration of lymph nodes

8.1

8.9

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

10.9

8.8

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

6.1

8.8

CJB10

NOMESCO Finland

Laser discission of secondary cataract

3.1

8.8

159

C02EA02

ATC

4.1

8.8

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

8.7

264

1901

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

14.3

8.7

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

7.8

8.7

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

7.8

8.7

ZX196

NOMESCO Finland

50.7

8.7

120

Kela drug reimbursment

Hypogammaglobulinaemia

50.7

8.7

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

50.7

8.7

7151

FHL

Kidney transplantation

50.7

8.7

K65.8

ICD-10 Finland

Other peritonitis

50.7

8.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

8.6

133

771

B27.0

ICD-10 Finland

Gammaherpesviral mononucleosis

11.8

8.6

CKC12

NOMESCO Finland

Photocoagulation of retina

3.7

8.6

101

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.8

8.6

220

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

8.5

150

910

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.6

8.5

107

XF612

NOMESCO Finland

Measurement of central venous pressure

27.9

8.5

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

27.9

8.5

M01AH05

ATC

etoricoxib; oral

0.6

8.5

195

2692

K06.18

ICD-10 Finland

Another gingival hyperplasia

20.4

8.5

T89

ICPC

Diabetes insulin dependent

3.9

8.5

H02AB07

ATC

prednisone; oral

2.2

8.4

456

Q61.0

ICD-10 Finland

Congenital single renal cyst

91.3

8.4

JL9AE

NOMESCO Finland

Ultrasound examination of pancreas transplant

91.3

8.4

58209

ICD-8 Finland

Chronic nephritis, Unspecified

91.3

8.4

D46.9

ICD-10 Finland

Myelodysplastic syndrome, unspecified

91.3

8.4

WW304

NOMESCO Finland

Transfer of stem cells from registered domestic donator

91.3

8.4

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

6.9

8.4

JN6AD

NOMESCO Finland

CT of torso and neck

8.0

8.4

C82.1

ICD-10 Finland

Follicular lymphoma grade II

13.0

8.4

WX140

NOMESCO Finland

Parabulbar anesthesy

4.1

8.4

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.1

8.4

XX1XW

NOMESCO Finland

Extensive written report from radiologist

6.0

8.4

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

+∞

8.3

C92.9

ICD-10 Finland

Myeloid leukaemia, unspecified

+∞

8.3

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

+∞

8.3

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

8.3

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

8.7

8.3

C09CA01

ATC

losartan; oral

1.9

8.3

137

810

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

9.6

8.3

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

8.3

300

2257

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

7.2

8.3

H26.2

ICD-10 Finland

Complicated cataract

7.2

8.3

N05BA06

ATC

lorazepam; systemic, sublingual

3.7

8.3

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.0

8.3

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

14.7

8.2

UKC02

NOMESCO Finland

Cystoscopy

2.1

8.2

461

P01AB01

ATC

metronidazole; oral, rectal

1.7

8.2

226

1578

M05BX04

ATC

denosumab; parenteral

4.2

8.2

C10AA04

ATC

fluvastatin; oral

2.8

8.1

198

N02BE01

ATC

paracetamol; systemic, rectal

1.9

8.1

488

4241

R04.0

ICD-10 Finland

Epistaxis

2.9

8.1

168

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

17.5

8.1

M10.3

ICD-10 Finland

Gout due to impairment of renal function

33.8

8.1

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

5.4

8.1

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

10.2

8.1

D07AB08

ATC

desonide; topical

2.4

8.0

317

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

22.4

8.0

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.1

7.9

148

1XC02

NOMESCO Finland

13.2

7.9

K50.8

ICD-10 Finland

Other Crohn disease

6.2

7.9

WX720

NOMESCO Finland

Own respiration

3.4

7.9

109

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

2.2

7.8

416

L01BB02

ATC

mercaptopurine; oral

9.6

7.8

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

9.6

7.8

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.8

7.8

176

1150

E86

ICD-10 Finland

Volume depletion

5.7

7.7

2AX04

NOMESCO Finland

45.6

7.7

2503B

ICD-9 Finland

Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]

45.6

7.7

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

45.6

7.7

N0830, E102

ICD-10 Finland

45.6

7.7

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

4.9

7.7

WX704

NOMESCO Finland

Intubation

2.6

7.7

230

H26.4

ICD-10 Finland

After-cataract

2.8

7.7

187

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.0

7.7

RS221

NOMESCO Finland

6.8

7.6

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

8.2

7.6

H3600, E103

ICD-10 Finland

8.2

7.6

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

6.3

7.6

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

25.4

7.6

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

25.4

7.6

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

25.4

7.6

E21.2

ICD-10 Finland

Other hyperparathyroidism

25.4

7.6

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.5

7.6

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

10.2

7.6

H3603, E113

ICD-10 Finland

10.2

7.6

H30.1

ICD-10 Finland

Disseminated chorioretinal inflammation

81.0

7.4

N0832, E102

ICD-10 Finland

81.0

7.4

N083, E102

ICD-10 Finland

81.0

7.4

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.5

7.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.1

7.4

H36.01

ICD-10 Finland

Diabetic maculopathy

7.0

7.3

A40.8

ICD-10 Finland

Other streptococcal sepsis

11.0

7.3

1XX32

NOMESCO Finland

+∞

7.3

B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

7.3

07959

ICD-8 Finland

Other viral diseases, Virosis cytomegalica NUD

+∞

7.3

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

+∞

7.3

K05.31

ICD-10 Finland

Periodontitis pronounced

2.3

7.3

299

E000001

ATC

1.9

7.2

122

726

201

Kela drug reimbursment

Chronic cardiac insufficiency

3.6

7.2

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

30.4

7.2

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

30.4

7.2

E83.51

ICD-10 Finland

Hypocalcemia

20.3

7.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.8

7.1

169

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

8.1

7.1

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

8.1

7.1

C03DA01

ATC

spironolactone; oral

2.4

7.1

274

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

7.1

262

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

10.2

7.1

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.3

7.0

276

I50.1

ICD-10 Finland

Left ventricular failure

3.5

7.0

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

7.0

139

872

K50.1

ICD-10 Finland

Crohn disease of large intestine

6.4

7.0

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

7.7

6.9

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

14.0

6.9

I15.0

ICD-10 Finland

Renovascular hypertension

14.0

6.9

RJ421

NOMESCO Finland

14.0

6.9

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

14.0

6.9

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.5

6.9

C03AA03

ATC

hydrochlorothiazide; oral

2.4

6.9

239

RS222

NOMESCO Finland

8.4

6.9

G04CA02

ATC

tamsulosin; oral

1.8

6.9

122

736

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

6.8

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

6.8

187

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

11.1

6.8

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

9.5

6.8

S18

ICPC

Laceration/cut

1.6

6.8

228

1656

J96.1

ICD-10 Finland

Chronic respiratory failure

6.2

6.8

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.3

6.8

100

WX202

NOMESCO Finland

Supraclavicular plexus blockade

5.8

6.8

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.8

6.8

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

3.7

6.8

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

40.5

6.8

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

40.5

6.8

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

40.5

6.8

L04AA10

ATC

sirolimus; oral

40.5

6.8

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

40.5

6.8

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

40.5

6.8

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

40.5

6.8

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

40.5

6.8

B72

ICPC

Hodgkin Lymphoma

40.5

6.8

I50.0

ICD-10 Finland

Congestive heart failure

3.0

6.7

132

R51.80

ICD-10 Finland

Headache

2.0

6.7

485

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

22.8

6.7

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.7

6.7

E0000UV

ATC

1.6

6.7

218

1573

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

5.6

6.6

D11AH01

ATC

tacrolimus; topical

7.9

6.6

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.9

6.6

100

569

UJF02

NOMESCO Finland

Peroral enteroscopy

12.4

6.6

NGQ20

NOMESCO Finland

Amputation of lower leg

12.4

6.6

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

12.4

6.6

KAC00

NOMESCO Finland

Nephrectomy

12.4

6.6

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.7

6.6

J12.8

ICD-10 Finland

Other viral pneumonia

10.2

6.6

H3601, E103

ICD-10 Finland

7.0

6.5

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

6.5

280

R18

ICD-10 Finland

Ascites

5.4

6.5

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

5.4

6.5

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.5

6.5

N05CD07

ATC

temazepam; oral

2.2

6.5

321

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

7.5

6.4

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

70.5

6.4

KAS40

NOMESCO Finland

Excision of transplanted kidney

70.5

6.4

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

70.5

6.4

RJ422

NOMESCO Finland

70.5

6.4

474

NOMESCO Finland

70.5

6.4

H3603, E107

ICD-10 Finland

70.5

6.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

14.5

6.4

C09AA05

ATC

ramipril; oral

1.8

6.4

126

784

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

8.3

6.4

WX730

NOMESCO Finland

Conventional respirator

5.6

6.3

K51.8

ICD-10 Finland

Other ulcerative colitis

5.6

6.3

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

11.2

6.3

JMA10

NOMESCO Finland

Transabdominal total splenectomy

11.2

6.3

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

11.2

6.3

WX725

NOMESCO Finland

Noninvasive ventilation

2.9

6.3

128

C83.1

ICD-10 Finland

Mantle cell lymphoma

18.2

6.3

Y83.0

ICD-10 Finland

Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

18.2

6.3

N08.3

ICD-10 Finland

Glomerular disorders in diabetes mellitus

+∞

6.3

1507

Kela drug reimbursment

Pomalidomide

+∞

6.3

KAB00

NOMESCO Finland

Biopsy of kidney or pelvis of kidney

+∞

6.3

L04AX06

ATC

pomalidomide; oral

+∞

6.3

4039A

ICD-9 Finland

Hypertensive renal disease, Unspecified

+∞

6.3

393

Kela drug reimbursment

Pomalidomide

+∞

6.3

BBA50

NOMESCO Finland

Total parathyroidectomy

+∞

6.3

D80.2

ICD-10 Finland

Selective deficiency of immunoglobulin A [IgA]

+∞

6.3

C92.5

ICD-10 Finland

Acute myelomonocytic leukaemia

+∞

6.3

K77.0*B25.1

ICD-10 Finland

Cytomegaloviral hepatitis

+∞

6.3

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

27.0

6.2

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.7

6.2

161

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

6.4

6.2

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

5.4

6.2

C08CA10

ATC

nilvadipine; oral

5.4

6.2

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

5.8

6.2

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

6.2

313

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

7.8

6.1

WX203

NOMESCO Finland

Infraclavicular plexus blockade

3.8

6.1

602

Kela drug reimbursment

Children's severe malnutrition

12.7

6.1

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

12.7

6.1

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.1

6.1

345

UJF92

NOMESCO Finland

Capsular endoscopy

4.2

6.1

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

6.1

256

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

10.2

6.0

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

5.6

6.0

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.7

6.0

151

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3010375) cycloSPORINE [Mass/volume] in Blood

169

99.00

322.53

37.9

36.8

ug/l

123.5

150.3

0.74

142

(3026250) Tacrolimus [Mass/volume] in Blood

189

115.53

307.65

42.2

30.4

ug/l

7.5

6.8

0.90

171

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

237

110

33.36

307.65

2.4

1.6

u/ml

102.8

102.5

0.01

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

252

121

33.41

307.65

2.3

1.5

u/ml

29.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

254

119

34.43

307.65

2.4

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

311

63.99

307.65

5.9

5.3

u/ml

786.6

2031.6

0.38

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

394

121

81.33

307.65

22.0

5.7

iu/ml

4790.3

252.4

1.03

241

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

236

134

27.10

306.86

1.6

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

232

129

27.43

304.28

1.6

1.4

u/ml

267.3

250.9

0.19

170

(3048929) Epstein Barr virus Ab [Presence] in Serum

249

208

18.80

264.73

1.7

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

388

660

13.13

252.57

31.0

6.2

mmol/l

1.1

1.0

3.55

382

616

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

166

35.06

249.76

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

166

32.95

244.42

2.4

2.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

340

537

12.20

232.10

12.8

4.9

u/l

274.0

239.5

2.96

333

509

(40768446) Kidney Pathology biopsy report

112

71.03

204.24

2.4

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

252

360

10.81

181.70

3.7

1.5

—

(3042733) HLA Ab [Presence] in Serum

101

62.77

180.31

5.2

3.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

167

144

15.27

170.32

4.1

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

251

386

9.97

169.52

7.3

2.9

e9/l

72.7

71.9

0.10

192

291

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

241

358

10.12

167.27

12.8

3.9

ng/l

182.8

73.1

17.42

229

323

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

186

197

12.83

166.13

3.2

2.0

g/l

1.4

1.5

0.44

168

170

(3012095) Magnesium [Moles/volume] in Serum or Plasma

354

829

8.19

162.58

15.6

4.2

mmol/l

0.8

4.40

348

783

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

162

144

14.66

161.85

4.4

1.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

319

675

8.33

161.36

8.0

2.2

24.1

23.2

0.45

283

586

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

112

28.59

160.71

1.4

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

285

538

8.66

160.19

8.0

3.0

2.1

1.7

3.63

277

497

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

93.71

156.28

5.8

4.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

324

721

7.98

155.31

7.9

2.2

g/l

2.1

2.4

19.21

317

674

(3023368) Bacteria identified in Blood by Culture

443

1350

8.19

154.40

13.4

4.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

255

455

8.58

149.79

6.7

2.5

g/l

8.5

10.4

6.98

245

419

(3022948) Iron [Moles/volume] in Serum or Plasma

331

777

7.65

149.71

7.9

2.2

umol/l

12.1

13.5

2.75

325

723

(3017143) Hepatitis C virus Ab [Presence] in Serum

303

655

7.80

148.50

3.1

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

148

139

13.50

142.10

2.1

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

327

795

7.27

141.54

4.6

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

147

12.64

135.21

5.0

7.0

u/ml

0.3

0.4

2.59

(3024471) HLA-A [Type]

40.66

132.98

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

320

806

6.86

132.11

3.0

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

266

561

7.34

131.64

3.4

1.9

—

(3024932) HLA-DR beta [Type]

40.10

130.89

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

265

564

7.25

129.76

3.5

2.0

—

(3017181) Myelocytes/100 leukocytes in Blood

235

449

7.64

127.63

11.1

4.5

0.8

0.01

150

143

(3002179) Metamyelocytes/100 leukocytes in Blood

221

401

7.84

125.87

10.5

4.6

0.7

0.3

3.35

118

102

(3021447) Carbon dioxide [Partial pressure] in Venous blood

235

463

7.39

123.54

15.9

4.7

kpa

5.7

5.8

0.12

230

452

(42870588) Differential panel, method unspecified - Blood

475

1800

7.11

122.93

22.9

6.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

45.57

122.12

1.1

—

(3002032) Base excess in Venous blood by calculation

233

460

7.34

122.11

16.3

4.8

mmol/l

0.8

2.0

4.17

197

363

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

49.70

121.25

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

119

104

13.79

118.81

4.9

1.9

—

(3011412) CD3 cells [#/volume] in Blood

18.75

118.03

4.7

2.0

e9/l

1.4

1.0

1.76

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

116

105

13.23

113.14

2.7

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

400

1376

5.97

113.05

9.5

2.6

umol/l

374.1

5998.6

4.37

387

1190

(46235355) HIV 1 and 2 tests - Meaningful Use set

333

988

5.87

111.57

3.1

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

108

14.36

111.54

3.0

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

211

411

7.13

111.13

2.1

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

198

362

7.43

110.86

2.6

1.6

g/l

1.2

1.4

0.64

179

332

(3018677) aPTT in Platelet poor plasma by Coagulation assay

290

770

6.00

110.03

5.1

2.9

29.3

29.8

0.55

284

748

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

165

250

8.51

109.48

15.7

5.6

mmol/l

23.3

24.2

2.59

158

229

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

16.39

107.95

3.2

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

16.79

106.16

1.2

—

(3042936) Bacteria identified in Isolate by Culture

287

777

5.83

105.95

3.5

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

15.73

104.46

1.2

1.1

—

(44806118)

102

14.05

104.46

2.6

1.8

—

(44790049)

102

14.05

104.46

2.6

1.8

—

(44790047)

102

14.05

104.46

2.6

1.8

—

(44790048)

102

14.05

104.46

2.6

1.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

101

14.23

104.30

8.9

3.5

1.3

1.5

0.14

(3018418) pH of Serum or Plasma

405

1499

5.53

102.21

23.9

3.8

7.4

0.43

270

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

17.47

101.78

2.7

1.8

—

(3000991) Gas panel - Venous blood

205

430

6.51

99.27

20.4

11.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

490

2163

6.16

98.61

27.5

4.8

g/l

33.8

36.0

15.51

480

2029

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

20.01

98.06

3.4

2.0

10.9

12.9

0.36

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

37.30

97.03

4.7

2.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

139

201

8.53

95.35

3.5

2.2

ug/l

1.4

3.0

0.58

131

184

(3000850) Epithelial cells [#/volume] in Urine

326

1059

5.18

95.18

9.6

2.5

e6/l

3.4

5.6

1.82

312

934

(4035726)

207

461

6.12

93.62

2.3

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

18.45

93.16

5.0

2.1

e9/l

0.2

0.16

(21494815) CD4 cells/100 lymphocytes in Specimen

17.08

92.88

4.1

1.8

27.8

32.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

38.96

91.83

1.7

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

17.70

91.22

4.9

2.0

e6/l

893.9

485.0

2.35

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

13.59

91.13

9.1

7.4

mg/l

11.7

10.0

1.92

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

18.85

90.62

3.2

2.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

12.21

90.32

3.0

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

126

173

8.80

90.06

3.7

3.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

18.43

89.63

3.1

2.5

30.6

38.2

0.78

(3026782) Osmolality of Urine

304

976

4.98

88.99

10.5

2.7

mosm/kgh2o

476.6

566.5

14.38

288

838

(3022096) Basophils/100 leukocytes in Blood

513

2484

6.08

88.47

24.6

6.2

0.6

0.7

3.26

508

2323

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

434

1850

5.06

87.69

13.3

3.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

16.35

87.53

4.7

1.8

e6/l

506.7

815.1

1.06

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

512

2512

5.92

85.77

48.2

7.5

mmol/l

1.2

0.38

468

2146

(3019069) Monocytes/100 leukocytes in Blood

518

2569

6.04

85.53

26.7

6.5

8.7

0.01

513

2413

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

486

2296

5.45

85.11

35.5

7.1

mmol/l

1.2

0.54

474

2084

(3006504) Eosinophils/100 leukocytes in Blood

515

2558

5.91

84.39

25.4

6.2

2.1

2.9

13.16

507

2388

(3021440) Promyelocytes/100 leukocytes in Blood

189

423

5.89

84.28

12.0

4.7

0.1

0.64

141

128

(3006315) Basophils [#/volume] in Blood

532

2727

6.27

83.47

21.8

6.1

e9/l

0.0

6.76

506

2368

(3001604) Monocytes [#/volume] in Blood

531

2718

6.25

83.45

21.7

6.1

e9/l

0.6

1.30

505

2354

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

12.56

83.10

2.8

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

104

125

9.72

82.42

2.2

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

12.72

81.96

2.5

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

386

1562

4.63

81.95

12.7

3.1

e6/l

32.8

92.3

0.79

362

1204

(3025159) Blasts/100 leukocytes in Blood

181

399

5.90

81.88

11.0

4.7

0.0

0.1

0.35

121

108

(3002030) Lymphocytes/100 leukocytes in Blood

520

2643

5.87

81.63

25.7

6.2

28.6

0.01

515

2473

(3018010) Neutrophils/100 leukocytes in Blood

515

2611

5.71

80.70

23.5

6.0

56.6

56.4

0.15

510

2452

(3019198) Lymphocytes [#/volume] in Blood

533

2797

6.07

79.45

22.2

6.1

e9/l

2.1

0.01

514

2480

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

121

183

7.90

79.23

3.4

4.9

85.9

89.3

0.55

115

175

(3020630) Protein [Mass/volume] in Serum or Plasma

175

385

5.85

79.14

6.7

2.9

g/l

61.9

67.0

10.60

166

356

(3013115) Eosinophils [#/volume] in Blood

535

2823

6.10

79.00

24.1

6.5

e9/l

0.1

0.2

12.74

511

2493

(3030467) Casts [#/volume] in Urine by Automated count

361

1420

4.48

78.90

11.6

3.1

e6/l

0.3

0.4

0.37

325

1062

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

11.39

78.70

2.6

1.8

—

(36304419) Bacteria [Presence] in Urine

353

1385

4.40

76.97

10.7

3.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

35.25

76.84

1.5

3.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

200

512

5.20

75.82

5.2

3.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

166

379

5.54

71.53

11.2

5.3

kpa

4.9

5.1

3.66

158

358

(3009343) pH of Capillary blood

164

373

5.55

70.94

11.1

5.4

7.4

1.17

(3007853) Bacteria identified in Skin by Aerobe culture

215

625

4.65

68.99

2.3

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

157

359

5.45

67.26

11.3

5.5

mmol/l

0.8

1.5

1.41

118

273

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

250

829

4.28

67.10

7.7

2.8

e6/l

2.2

2.0

0.13

175

453

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

9.84

67.01

12.9

2.7

—

(3018095) Leukocytes [#/volume] in Urine

398

1830

4.04

66.49

14.4

3.6

e6/l

125.6

95.0

0.24

365

1290

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

110

181

7.11

66.25

2.1

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

374

1657

3.97

65.83

8.5

2.5

u/l

56.0

57.2

0.24

362

1533

(3013650) Neutrophils [#/volume] in Blood by Automated count

544

3137

5.54

65.62

37.2

9.5

e9/l

3.9

4.0

0.42

523

2740

(3032080) INR in Blood by Coagulation assay

421

2027

4.07

65.34

20.4

7.6

inr

1.1

1.2

0.59

144

585

(1616796) Gas panel - Central venous blood

102

9.18

64.23

9.9

2.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

207

618

4.45

63.60

14.5

3.2

umol/l

8.6

8.2

0.08

194

543

(3014111) Lactate [Moles/volume] in Serum or Plasma

175

459

4.85

63.44

16.3

10.1

mmol/l

1.4

1.3

0.06

170

444

(3045142) Bone marrow Pathology biopsy report

11.40

63.39

1.9

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

253

881

4.07

62.82

6.6

2.7

e6/l

0.7

1.0

1.13

175

499

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

304

1211

3.84

61.82

3.3

2.1

mg/l

3.1

3.0

0.29

286

1037

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

138

7.70

61.41

1.8

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

139

308

5.47

61.38

6.0

2.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

134

7.74

60.48

6.2

3.7

mmol/l

22.8

24.8

3.54

117

(3000093) Morphology [Interpretation] in Blood Narrative

14.11

60.40

1.4

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

134

297

5.43

59.03

2.0

1.5

—

(3000494) Fungus identified in Specimen by Culture

210

682

4.07

56.81

3.3

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

116

7.95

56.34

2.6

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

304

1280

3.59

55.53

6.5

2.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

9.85

55.52

5.2

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

18.52

55.40

2.2

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

157

418

4.64

55.29

7.0

2.5

ml/min/173m2

40.0

70.3

15.45

169

(3044640) Blood type and Crossmatch panel - Blood

354

1649

3.52

54.87

8.5

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

10.61

54.46

5.4

2.0

—

(3037756) Immunofixation for Serum or Plasma

100

8.35

54.13

3.5

1.6

—

(3024928) Oxygen saturation in Venous blood

109

8.00

54.11

11.8

5.0

—

(3025941) Bacteria identified in Stool by Culture

130

302

5.13

54.00

1.8

1.3

—

(3016502) Oxygen saturation in Arterial blood

173

507

4.29

53.61

15.1

11.4

94.8

95.9

1.21

166

489

(21494814) CD8 cells/100 lymphocytes in Specimen

25.16

53.37

3.0

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

512

3047

4.22

53.30

23.7

5.3

mmol/l

6.8

6.7

0.60

497

2857

(3027273) Bicarbonate [Moles/volume] in Venous blood

112

231

5.65

53.20

11.7

3.5

mmol/l

24.0

25.0

1.92

107

224

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

181

556

4.13

52.50

14.9

10.8

kpa

4.8

5.1

4.13

172

535

(3027801) Oxygen [Partial pressure] in Arterial blood

181

556

4.13

52.50

14.9

10.8

kpa

11.6

12.4

1.41

170

536

(3003396) Base excess in Arterial blood by calculation

178

552

4.07

50.80

15.0

11.0

mmol/l

-0.1

1.1

3.62

144

442

(3008536) Aspergillus sp Ab [Presence] in Serum

29.84

50.69

5.2

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

145

6.68

50.18

7.8

3.9

mg/l

75.4

97.9

0.20

118

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

145

6.68

50.18

7.8

3.9

mg/l

38.9

31.8

0.65

119

(3021901) Oxygen saturation in Capillary blood

100

7.97

50.13

5.7

2.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

143

6.69

49.69

7.8

3.8

ratio

1.8

2.1

—

(3026008) Bacteria identified in Urine by Culture

309

1391

3.33

49.36

6.3

2.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

9.98

48.12

1.8

1.2

—

(40758558) Short blood count panel - Blood

299

1341

3.28

47.70

25.9

7.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

106

7.52

47.59

4.2

2.0

g/l

119.7

132.4

3.24

(40760888) Immunoglobulin light chains.free panel - Serum

113

7.26

47.32

7.2

4.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

7.76

47.06

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

100

7.60

46.22

5.2

2.4

15.3

16.8

1.91

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

161

497

3.98

45.84

5.0

2.3

g/l

0.2

0.02

153

465

(3002173) Hemoglobin [Mass/volume] in Arterial blood

156

471

4.04

45.83

16.5

11.3

g/l

107.7

122.1

13.49

148

456

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

31.41

45.44

2.7

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

13.04

44.84

3.5

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

10.19

44.75

10.2

3.1

55.4

54.4

0.08

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

14.52

44.58

2.9

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

160

501

3.91

44.54

3.1

2.0

nmol/l

333.9

366.2

0.82

151

468

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

137

6.33

43.57

3.2

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

108

7.03

43.05

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

14.14

42.86

2.9

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

14.76

42.82

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

14.76

42.82

1.2

1.0

—

(21494434) Karyotype in Bone marrow

10.31

42.63

1.5

1.3

—

(3012516) Albumin [Mass/volume] in Urine

309

1487

3.06

42.47

9.3

3.2

mg/l

1083.4

274.7

1.53

272

954

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

12.38

42.46

1.8

1.4

—

(3011648) Oxygen content in Venous blood

10.70

42.04

10.9

6.6

10.8

10.9

0.06

(3021589) Normoblasts [#/volume] in Blood

422

2425

3.12

41.86

35.8

9.3

e9/l

0.0

0.61

363

1978

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

102

7.09

41.64

9.3

3.9

53.6

54.5

0.15

102

(3001964) Herpes simplex virus Ag [Presence] in Specimen

24.15

41.49

3.2

2.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

110

275

4.61

41.27

20.9

15.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

9.59

41.22

1.1

1.0

—

(3012501) Base excess in Blood by calculation

7.21

41.10

11.5

3.9

mmol/l

2.7

2.4

0.17

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

424

2462

3.08

40.91

12.5

3.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

270

1237

3.03

40.03

13.7

4.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

160

5.64

39.96

4.0

2.3

ug/l

295.1

289.1

0.03

149

(3006922) Hepatitis E virus Ab [Presence] in Serum

12.90

39.61

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

15.36

39.34

3.1

2.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

129

6.15

39.33

7.0

3.4

umol/l

35.0

35.3

0.03

103

(3007164) IgA [Mass/volume] in Serum or Plasma

254

1140

3.02

38.86

2.4

1.4

g/l

2.0

2.4

2.52

205

706

(3010421) pH of Blood

120

6.32

38.83

13.5

3.7

7.4

0.63

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

17.66

38.67

8.2

2.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

17.66

38.67

8.2

2.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

17.66

38.67

7.1

1.7

—

(3009508) Creatinine [Moles/volume] in Urine

323

1657

2.89

38.51

9.1

3.1

mmol/l

6.0

8.0

18.28

310

1378

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

14.74

38.47

3.1

2.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

8.16

38.32

11.4

3.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

253

1145

2.98

37.97

1.9

1.5

nmol/l

18.4

20.9

1.84

233

960

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

343

1827

2.86

37.90

12.6

3.4

u/l

36.3

32.8

0.49

335

1739

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

16.78

37.70

8.2

2.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

14.89

37.60

8.0

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

14.89

37.60

8.0

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

14.89

37.60

8.0

2.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

14.89

37.60

8.0

2.2

—

(3000060) B lymphocytes [#/volume] in Blood

14.89

37.60

3.4

2.1

e6/l

288.7

401.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

9.60

37.26

3.8

2.3

33.2

33.0

0.11

(3015377) Calcium [Moles/volume] in Serum or Plasma

323

1682

2.83

37.04

11.6

3.2

mmol/l

2.3

2.4

4.87

313

1490

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

9.41

36.71

6.7

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

9.41

36.71

6.7

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

9.41

36.71

6.7

1.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

509

3386

3.33

36.60

11.2

4.0

e6/l

24.4

790.1

—

(3022313) Gas panel - Capillary blood

106

283

4.28

36.35

13.3

5.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

18.93

36.21

2.5

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

308

1580

2.81

36.13

10.6

3.9

mg/mmol

27.3

8.5

3.53

269

996

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

111

6.29

36.06

1.5

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

12.70

35.28

3.1

1.9

—

(3019060) Gas panel - Arterial blood

110

310

4.07

35.01

10.2

6.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

294

1514

2.72

33.64

4.2

2.1

u/l

129.8

250.9

1.87

283

1437

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

8.79

33.33

5.6

2.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

14.93

33.26

3.4

2.0

ug/l

64.0

73.6

0.15

(3051651) Icteric interference index of Serum or Plasma

10.54

32.99

8.2

3.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

247

1176

2.78

32.82

3.8

2.0

mg/l

2.3

1.2

1.05

220

887

(3028433) Virus identified in Specimen by Culture

13.51

32.49

1.6

1.5

—

(40768441) Liver Pathology biopsy report

10.53

32.08

3.9

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

258

4.14

31.67

15.8

14.5

mmol/l

23.2

24.4

4.03

246

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

23.81

31.59

3.3

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

270

1370

2.66

31.33

5.7

3.2

ng/l

3541.8

927.0

5.14

256

1155

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

167

4.87

31.20

7.8

2.4

g/l

3.1

0.23

134

(3019309) Folate [Moles/volume] in Red Blood Cells

193

829

2.89

30.93

2.1

1.7

nmol/l

1239.0

1194.8

0.24

166

639

(3037467) Urinalysis macro (dipstick) panel - Urine

516

3615

3.09

30.74

15.5

4.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

11.55

30.43

3.2

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

11.55

30.43

3.2

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

179

4.68

30.41

8.1

2.4

g/l

3.2

3.8

4.18

132

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

179

4.68

30.41

8.1

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

179

4.68

30.41

8.1

2.4

g/l

7.0

7.3

0.65

138

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

150

5.03

30.39

6.3

2.7

g/l

0.6

1.2

0.85

138

(3051611) Lipemic interference index of Serum or Plasma

8.76

30.28

8.4

3.3

—

(40757373) Influenza virus identified in Isolate

19.13

30.11

2.5

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

203

4.42

29.97

11.5

7.8

1.6

0.11

192

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

14.78

29.80

1.1

1.0

miu/ml

1622.3

1605.3

0.02

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

103

5.86

29.63

1.7

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

138

502

3.22

29.53

6.3

2.3

u/l

37.2

129.3

0.48

127

427

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

206

940

2.75

29.19

7.1

3.7

ng/l

656.6

391.1

0.44

176

710

(3019832) Treponema pallidum Ab [Presence] in Serum

136

495

3.21

29.04

2.3

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

9.02

28.64

3.8

2.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

67.17

28.18

11.8

2.8

mmol/l

5.1

7.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

295

3.74

28.15

2.6

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

287

3.75

27.84

8.9

2.3

e6/l

0.3

0.1

0.39

275

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

8.60

27.61

1.7

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

164

4.59

27.24

8.0

2.4

g/l

8.0

10.7

5.23

144

(3017817) Protein [Mass] in Urine collected for unspecified duration

8.91

26.86

4.0

2.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

332

1962

2.42

26.65

2.4

1.9

pmol/l

98.6

95.0

0.87

209

1036

(3007930) Methemoglobin/Hemoglobin.total in Blood

199

4.19

26.48

12.2

8.0

1.0

0.9

0.42

189

(3009445) Proteinase 3 Ab [Units/volume] in Serum

242

3.89

26.40

2.9

1.4

u/ml

16.3

8.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

5.95

26.06

1.9

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

5.95

26.06

1.9

1.4

—

(3003694) ABO and Rh group [Type] in Blood

276

1516

2.43

25.95

1.9

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

301

3.57

25.86

13.9

9.3

mmol/l

23.6

24.5

1.27

283

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

6.11

25.73

4.5

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

160

4.48

25.39

7.1

2.9

—

(3047181) Lactate [Moles/volume] in Blood

148

4.61

25.20

15.6

10.4

mmol/l

1.2

0.07

130

(3024522) Salmonella sp identified in Specimen by Organism specific culture

5.96

25.09

4.5

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

5.96

25.09

4.5

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

160

4.40

24.51

1.4

1.2

titre

104.3

56.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

7.41

24.39

1.5

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

7.65

24.39

1.3

1.1

titre

256.3

62.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

9.20

24.35

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

9.20

24.35

1.5

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

398

2615

2.35

24.16

10.7

3.4

estimate

0.0

0.80

115

447

(3035350) Ketones [Presence] in Urine by Test strip

393

2580

2.33

23.74

10.8

3.4

estimate

0.0

0.00

114

464

(3023419) Bacteria identified in Sputum by Culture

6.08

23.49

3.1

2.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

392

2588

2.30

23.11

14.1

4.6

estimate

0.0

0.00

118

478

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

5.68

22.90

4.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

5.68

22.90

4.6

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

10.79

22.80

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

5.61

22.61

4.6

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

165

756

2.59

22.47

1.6

1.3

titre

343.2

504.2

1.14

157

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

8.63

22.41

4.0

1.4

g/l

1.0

0.15

(3016750) Collection duration of Urine

9.35

22.21

4.9

2.7

min

487.3

502.5

0.32

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

168

4.12

22.15

1.5

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

315

1926

2.23

22.06

5.1

3.4

ng/l

77.6

40.9

0.79

259

1305

(3009871) Measles virus Ab [Titer] in Serum

13.53

22.06

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

169

4.09

21.97

1.5

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

110

413

3.00

21.90

2.6

2.3

ug/l

17.0

7.1

1.29

100

370

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

102

367

3.11

21.87

7.3

3.7

ng/l

256.1

158.8

1.48

332

(42529406) Shigella sp [Presence] in Stool by Culture

171

4.04

21.62

1.5

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

519

3947

2.57

20.97

10.1

4.0

mm/h

20.9

10.8

23.21

508

3646

(3039000) Anion gap in Blood

109

4.78

20.90

16.9

12.0

mmol/l

11.6

11.1

0.55

100

(3018572) Chloride [Moles/volume] in Blood

109

4.78

20.90

16.9

12.0

mmol/l

104.3

106.0

1.11

100

(3044290) Cell count panel - Cerebral spinal fluid

105

4.86

20.88

2.0

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

185

3.86

20.85

2.0

1.5

g/l

0.3

0.2

0.89

178

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

256

3.42

20.75

15.4

6.1

mmol/l

24.0

24.8

2.08

245

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

8.49

20.64

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

4.98

20.64

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

178

3.88

20.43

1.9

1.5

iu/ml

0.0

1.21

(3048689) Calprotectin [Mass/mass] in Stool

151

694

2.53

20.22

3.8

2.4

ug/g

227.2

128.4

2.88

133

547

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

37.06

19.96

2.7

6.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

11.39

19.86

1.1

1.2

—

(3037121) Protein [Mass/volume] in Urine

202

3.58

19.01

8.9

4.0

g/l

0.4

0.3

0.32

100

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

8.86

19.00

1.3

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

6.79

18.89

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

189

3.65

18.72

7.6

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

216

1201

2.20

18.44

7.7

3.3

—

(3004775) Volume in Urine collected for unspecified duration

7.09

18.38

4.6

2.4

704.4

650.6

0.22

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

121

4.30

18.34

1.6

1.2

mmol/l

3.8

0.12

113

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

6.50

18.15

1.5

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

125

4.16

17.58

1.9

1.3

e6/l

228.3

1001.4

0.43

102

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

125

4.16

17.58

1.9

1.3

e6/l

3.3

10.5

0.68

100

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

147

3.84

16.95

1.1

—

(40758292) HTLV I+II Ab panel - Serum

13.65

16.84

1.8

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

5.65

16.81

1.2

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

15.33

16.80

1.6

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

15.33

16.80

1.9

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

144

3.84

16.67

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

174

3.56

16.55

1.2

1.4

miu/ml

271.8

222.4

—

(3042631) Mycobacterium sp identified in Specimen

5.38

16.43

2.5

3.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

6.51

16.40

1.4

1.3

e6/l

595.3

3266.7

1.34

(40768804) Tissue Pathology biopsy report

313

2069

1.99

16.27

3.0

2.1

—

(3017704) Immunofixation for Urine

7.66

16.20

2.6

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

162

3.62

16.12

1.5

1.4

ug/g

285.5

307.9

0.35

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

177

3.50

16.12

3.8

1.7

—

(40761535) Cells panel - Urine sediment

100

423

2.61

15.65

10.0

3.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

39.09

15.45

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

8.57

15.45

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

9.72

15.28

1.1

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

4.47

15.20

1.4

1.6

—

(40768795) Lymph node Pathology biopsy report

5.57

15.07

1.6

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

4.59

14.90

1.4

1.2

u/ml

3.8

4.2

0.09

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

10.91

14.70

3.8

1.4

e6/l

4822.0

6467.1

—

(3048879) Bone marrow aspiration report

10.91

14.70

5.4

2.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

11.79

14.46

1.6

1.3

—

(4306422)

4.51

14.21

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

10.23

14.07

12.8

10.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

7.20

14.05

4.5

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

4.49

13.74

1.4

1.2

u/ml

1.9

2.4

0.20

(3026389) Candida sp identified in Specimen by Organism specific culture

5.18

13.47

1.5

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

5.49

13.34

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.75

13.26

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

10.21

13.17

12.6

10.5

—

(3047189) Immunofixation for 24 hour Urine

7.69

12.75

3.3

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

7.69

12.75

1.5

1.3

u/l

23.7

14.9

1.07

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

4.29

12.64

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

189

3.09

12.62

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

220

1382

1.90

12.51

12.5

3.6

estimate

0.0

0.69

111

461

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

8.61

12.41

3.4

4.2

au/ml

117.2

37.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

4.07

12.14

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

27.28

12.09

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.99

11.86

8.6

3.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

30.65

11.68

20.6

22.2

umol/l

0.3

0.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

198

2.94

11.64

1.9

1.6

titre

560.0

180.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

144

3.28

11.61

1.5

1.2

—

(40768797) Stomach Pathology biopsy report

133

719

2.07

11.56

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

6.04

11.39

1.4

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

170

1009

1.93

11.31

1.8

1.7

pmol/l

515.1

5827931.3

0.50

157

858

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

25.53

11.18

2.4

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

8.06

11.05

2.3

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

289

2.55

10.93

1.5

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

134

3.28

10.89

5.7

2.6

ug/min

291.5

80.8

0.73

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

4.69

10.79

1.3

1.1

—

(3002256) Pathology report gross observation

121

649

2.06

10.69

1.4

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

5.39

10.65

1.5

1.4

e6/l

4925.6

30017.6

1.34

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

7.65

10.60

2.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

10.17

10.47

1.1

—

(3020891) Body temperature

193

2.84

10.41

11.3

4.9

—

(3049717) Cytology report of Urine Cyto stain

199

2.81

10.39

2.2

2.7

—

(3044889) 12 lead EKG panel

458

3707

1.80

10.34

6.8

3.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

4.23

10.25

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

5.13

10.10

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

217

1437

1.77

9.96

11.1

3.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

3.74

9.93

1.3

1.7

g/l

0.6

0.8

0.51

(40761539) Cells [Type] in Urine sediment by Light microscopy

9.39

9.90

1.8

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

9.39

9.90

1.7

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

5.26

9.89

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

4.49

9.87

3.3

3.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

111

593

2.05

9.87

27.1

18.8

inr

1.3

0.21

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

4.71

9.59

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.71

9.59

1.2

1.3

—

(40768806) Pleura Pathology biopsy report

4.90

9.59

1.3

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

217

1451

1.74

9.56

2.2

1.7

mmol/l

1.6

1.4

1.83

207

1226

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

7.13

9.32

1.1

—

(40765096) Chromosome analysis panel by Banding

7.13

9.32

1.1

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

458

3757

1.74

9.31

10.0

3.2

u/l

71.1

49.9

3.48

441

3538

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

280

2022

1.68

9.21

11.4

3.4

—

(3045424) Erythrocytes [Presence] in Urine

3.42

9.00

4.3

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

9.31

9.00

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

18.91

8.96

2.9

4.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

24.39

8.93

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

8.13

8.88

4.2

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

498

2.06

8.85

3.3

4.3

ug/l

30.1

34.4

0.06

414

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

181

2.72

8.80

2.0

2.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

200

2.63

8.69

3.0

3.6

u/ml

155.0

6217.9

0.66

173

(40761536) Microorganisms panel - Urine sediment

425

2.12

8.59

15.1

3.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

6.48

8.56

1.4

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

351

2.22

8.48

1.8

1.3

u/ml

390.9

262.9

0.21

324

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

7.62

8.43

1.2

1.1

—

(4268621)

4.11

8.12

2.4

2.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

9.22

8.10

2.5

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

9.22

8.10

2.5

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

9.22

8.10

3.5

2.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

9.22

8.10

2.5

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

6.61

8.09

1.8

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

7.17

8.02

2.3

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

178

2.64

8.01

4.8

4.5

mmol/l

1.6

1.4

0.39

173

(3017732) Neutrophils [#/volume] in Blood

374

2.14

7.95

3.6

3.0

e9/l

4.4

4.0

0.54

301

(3045788) Cell count panel - Pleural fluid

4.96

7.92

1.8

1.4

—

(3045414) Leukocytes [Presence] in Urine

222

2.46

7.92

5.8

1.6

—

(3035880) pH of Pleural fluid

5.94

7.88

1.1

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

3.81

7.69

1.1

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

4.06

7.66

3.1

2.5

umol/l

25.6

11.2

0.46

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

3.68

7.64

1.3

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

3.99

7.48

1.4

1.2

g/l

2.1

2.7

0.74

(3024139) IgG subclass 3 [Mass/volume] in Serum

3.99

7.48

1.4

1.2

g/l

0.4

0.3

0.49

(3027135) IgG subclass 1 [Mass/volume] in Serum

3.99

7.48

1.4

1.2

g/l

6.8

6.9

0.01

(3000012) Reticulocyte production index

6.01

7.40

2.2

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

6.01

7.40

1.6

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

3.18

7.37

1.2

1.1

—

11.6

—

(3019225) pH of Specimen

472

1.97

7.34

27.7

4.3

—

(4062490)

3.91

7.30

1.4

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

+∞

7.30

1.0

0.0

—

(3035933) Granulocytes/100 leukocytes in Blood

5.48

7.27

1.8

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

595

5414

2.19

7.27

77.6

13.1

mg/l

19.9

23.2

2.92

576

4219

(21494755) Public health laboratory ask at order entry panel

617

0.30

7.18

1.1

1.4

—

(3034426) Prothrombin time (PT)

6.98

7.17

1.2

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

6.98

7.17

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

6.98

7.17

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

3.12

7.13

1.1

iu/ml

29.7

30.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

3.23

7.06

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

6.09

6.92

4.2

2.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

138

881

1.72

6.89

4.6

2.8

mmol/l

2.5

2.4

0.14

128

782

(3019977) pH of Arterial blood

5.09

6.73

2.5

5.3

7.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

141

2.64

6.56

1.4

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

3.72

6.52

3.5

7.0

mmol/l

6.6

7.1

0.31

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

6.76

6.32

5.0

3.4

—

(3013512) EKG study

207

1492

1.57

6.31

6.0

3.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

429

3620

1.55

6.29

4.2

3.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

+∞

6.26

1.2

0.0

—

(3004451) EKG impression Narrative

4.75

6.24

1.4

1.3

—

(3022145) Colonoscopy Study observation

104

631

1.77

6.17

2.0

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.66

6.08

1.1

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

15.18

5.91

1.3

2.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.90

5.73

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

291

0.23

5.57

2.0

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

3.21

5.51

1.6

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

5.21

1.0

0.0

—

(3014891) Appearance of Pleural fluid

13.48

5.09

1.8

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

13.48

5.09

1.1

1.0

—

(40768443) Skin Pathology biopsy report

213

2.14

5.07

1.4

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

5.33

5.05

1.1

—

(1761868) Lipid panel - Serum or Plasma

154

2086

0.66

4.88

4.0

2.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

552

0.40

4.87

1.9

1.7

—

(3017569) Oxygen content in Arterial blood

4.35

4.84

1.5

3.8

—

(3023410) Appearance of Cerebral spinal fluid

3.13

4.82

2.2

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

9.11

4.79

1.9

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

247

2.02

4.72

2.5

2.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

594

5546

1.84

4.56

82.9

15.0

mmol/l

138.7

139.7

16.21

589

5397

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

10.11

4.53

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

317

1.87

4.49

3.5

3.3

pmol/l

4.2

4.6

2.12

283

(3036048) Francisella tularensis Ab [Titer] in Serum

7.59

4.36

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

8.98

4.29

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

8.98

4.29

1.0

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.66

4.22

1.1

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

457

4053

1.43

4.14

4.8

3.7

pmol/l

14.6

14.7

0.14

438

3685

(3023103) Potassium [Moles/volume] in Serum or Plasma

593

5564

1.76

4.05

86.3

15.1

mmol/l

4.1

4.0

12.74

587

5406

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

382

0.35

3.96

1.6

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2.77

3.95

3.5

3.0

nmol/l

1.1

0.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.84

3.81

1.0

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

161

2.11

3.78

1.6

2.1

u/l

1011.4

3952.9

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

12.09

3.77

1.2

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

12.09

3.77

1.2

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

12.09

3.77

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

12.09

3.77

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

12.09

3.77

2.2

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

141

1033

1.47

3.75

1.7

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.35

3.52

2.7

5.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

5.35

3.52

1.1

—

(3033799) Differential panel - Peritoneal fluid

6.22

3.51

2.0

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.93

3.48

2.1

1.3

—

(3022621) pH of Urine by Test strip

321

1.74

3.47

6.8

2.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

3.02

3.43

1.4

1.7

nmol/l

27.0

18.4

0.83

(3044927) Protein electrophoresis panel - Urine

2.87

3.37

1.3

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.06

3.37

1.1

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

128

2.16

3.34

2.2

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

6.42

3.19

1.9

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

6.42

3.19

2.4

8.7

mmol/l

1.2

—

(3025130) Human papilloma virus identified in Specimen

2.62

3.06

2.6

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

5.88

3.02

1.7

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

2.86

2.93

1.3

1.2

—

68.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

2.86

2.93

1.3

1.2

—

43.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.75

2.92

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

2.54

2.89

1.6

1.4

51.5

57.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

110

2.13

2.82

1.7

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

111

2.11

2.76

1.7

1.1

—

(3019150) Specific gravity of Urine by Refractometry

151

1179

1.37

2.76

9.4

3.5

kg/l

1.0

0.07

165

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

2.21

2.69

2.5

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.69

2.63

1.2

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.70

2.60

1.3

1.1

—

(3021788) Differential panel - Synovial fluid

2.22

2.59

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

2.76

2.56

1.2

1.1

mg/l

331.8

239.8

0.68

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

7.19

2.55

6.0

3.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

3.84

2.47

11.3

3.6

u/l

226.5

197.7

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

6.29

2.37

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.15

2.36

1.1

—

(3044941) Cell count panel - Synovial fluid

2.21

2.33

1.5

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.89

2.31

1.1

3.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

127

1.92

2.29

1.5

1.7

—

(1002224) Polysomnography panel

268

0.44

2.22

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.59

2.21

2.2

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.03

2.15

1.1

iu/ml

238.4

262.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

155

1261

1.30

2.11

1.4

1.3

u/ml

1.3

1.4

0.10

339

(4034850)

177

0.39

2.06

8.9

9.7

—

(3000330) Specific gravity of Urine by Test strip

248

1.61

2.03

12.3

3.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.84

2.00

1.0

1.4

—

26.6

—

(3004616) Nuclear Ab [Presence] in Serum

2.17

1.99

1.5

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

603

1.39

1.98

1.6

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

540

5120

1.33

1.95

56.8

11.8

ml/min/173m2

65.5

84.5

34.87

492

4187

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.57

1.94

1.0

—

(3022689) Creatine [Moles/volume] in Urine

4.57

1.94

5.6

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

4.57

1.94

5.8

12.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.99

1.94

1.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

520

4918

1.29

1.82

5.7

4.4

mu/l

2.0

2.1

0.27

502

4496

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.46

1.76

1.1

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

2.94

1.72

1.7

1.3

nmol/l

126.6

144.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

133

1.76

1.72

1.0

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

532

5057

1.29

1.71

68.1

14.4

35.2

40.5

34.28

410

3805

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

1.71

0.0

18.4

—

1524.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

136

1.72

1.61

1.4

1.8

pmol/l

197.9

225.4

0.83

129

(3035285) Chloride [Moles/volume] in Venous blood

2.05

1.55

2.7

2.6

mmol/l

108.5

105.2

1.64

(3041354) Potassium [Moles/volume] in Venous blood

2.05

1.55

2.7

2.6

mmol/l

4.4

4.0

1.22

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.44

1.54

2.6

1.4

ug/l

12.0

6.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

522

4970

1.26

1.53

11.5

5.5

mmol/mol

40.3

39.6

0.85

505

4629

(3014051) Protein [Presence] in Urine by Test strip

110

1.75

1.44

8.5

1.8

—

(4027681)

2.33

1.43

1.6

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

198

1.54

1.40

1.5

1.7

nmol/l

37.7

39.2

0.10

189

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

2.02

1.39

3.0

2.9

nmol/l

21.5

3.5

0.50

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

787

1.27

1.36

2.6

1.8

1.5

0.06

694

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.15

1.34

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.15

1.34

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.15

1.34

1.1

1.2

—

(3000492) Spirometry study

563

1.31

1.33

2.9

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1136

0.79

1.33

2.8

ug/l

0.8

0.7

0.42

705

(1761482) Bacteria [#/volume] in Urine by Culture

129

1.65

1.31

8.0

4.0

—

(4010399)

388

1.37

1.31

2.1

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.10

1.28

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.10

1.28

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.10

1.28

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.41

1.24

4.0

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.24

1.24

1.3

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.92

1.23

2.8

2.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

141

0.49

1.22

1.3

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.95

1.17

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.06

1.15

1.4

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.51

1.15

2.8

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

200

1.47

1.14

1.5

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

112

950

1.22

1.08

1.4

1.3

iu/ml

20.5

33.9

1.41

291

(3027944) Amphetamines [Presence] in Urine

239

0.62

1.04

2.6

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.07

1.03

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.87

0.97

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.23

0.93

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

153

0.58

0.89

1.8

1.4

—

(4024509)

1.92

0.89

3.3

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

103

1.57

0.88

1.4

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

274

1.33

0.86

1.1

titre

—

25.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.64

0.85

1.7

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

762

1.19

0.80

1.7

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

508

5232

0.87

0.78

8.5

4.4

mmol/l

6.1

5.9

1.00

486

4792

(40761511) CBC panel - Blood by Automated count

581

5687

1.21

0.75

61.3

12.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

116

1.48

0.75

4.1

3.5

mg/l

28.6

27.1

—

(4094501)

132

0.60

0.74

1.6

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

601

6100

0.80

0.73

98.8

19.3

e12/l

4.0

4.6

62.16

595

5934

(3028300) Cannabinoids [Presence] in Urine

240

0.70

0.71

3.7

1.7

—

(3027008) Opiates [Presence] in Urine

240

0.70

0.71

3.6

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

239

0.70

3.6

1.7

—

(3007461) Platelets [#/volume] in Blood

601

6096

0.81

0.68

99.1

19.4

e9/l

223.4

250.6

15.03

596

5943

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

532

5185

1.14

0.65

7.5

3.9

mmol/l

1.6

1.3

9.23

513

4785

(4281824)

1.61

0.61

1.4

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

588

1.17

0.58

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.43

0.52

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

225

0.75

0.51

3.6

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.48

0.47

1.3

1.2

nmol/l

0.5

0.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.40

0.44

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

387

1.17

0.44

1.2

iu/ml

216.6

142.8

—

156

(36660697) Celiac disease serology panel - Serum

434

1.16

0.43

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.41

0.0

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.36

0.41

1.4

1.3

nmol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

124

0.72

0.35

1.2

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

136

1.26

0.34

2.0

1.9

iu/l

5.1

6.1

—

(3008898) HLA-B27 [Presence]

249

0.84

0.29

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

633

1.10

0.29

17.9

6.4

—

(40768800) Prostate Pathology biopsy report

116

0.77

0.27

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

593

0.90

0.27

1.7

2.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.21

0.27

1.3

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

152

1.19

0.24

2.1

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

201

1937

1.05

0.24

4.0

4.5

ug/l

1.9

2.2

0.64

187

1736

(3020491) Glucose [Moles/volume] in Blood

1.19

0.21

6.0

1.6

mmol/l

9.6

6.3

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.21

0.0

5.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

149

1549

0.95

0.20

4.0

24.0

20.9

1.16

691

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

204

1.13

0.18

2.0

1.9

—

(3011985) Renin [Units/volume] in Plasma

1.13

0.17

1.7

1.3

mu/l

80.2

52.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.14

0.15

2.1

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

325

1.08

0.13

1.7

2.0

—

(40768793) Breast Pathology biopsy report

126

0.87

0.11

1.7

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

673

1.04

0.10

5.9

4.3

31.0

31.4

0.13

451

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

261

1.08

0.10

1.5

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

185

0.92

0.08

3.5

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

293

0.95

0.05

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

656

1.02

0.04

1.6

2.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

341

0.97

0.03

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

546

5472

0.99

0.02

7.5

4.8

mmol/l

2.5

2.8

10.32

528

5056

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

192

1.04

0.02

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

157

0.95

0.01

6.8

2.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

540

5393

1.01

0.01

7.6

4.3

mmol/l

4.4

4.7

6.73

524

5022

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

537

5364

1.01

0.00

7.5

4.3

mmol/l

1.3

1.4

7.41

520

4964

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

105

1.05

0.00

1.1

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

105

1.05

0.00

1.1

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

105

1.05

0.00

1.1

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

105

1.05

0.00

1.1

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

107

1.03

0.00

4.6

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

112

0.98

0.00

1.2

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

911

1.00

0.00

1.3

u/ml

4.5

12.4

1.40

361

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.0

1.9

—

0.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.99

0.00

1.1

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.00

0.00

1.3

1.6

—

(3005033) Fetal Nuchal fold Thickness US

0.99

0.00

1.1

1.4

—

(3001729) Color of Synovial fluid

0.00

0.0

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

65.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

1.00

0.00

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.96

0.00

1.1

1.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint CMV_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
CMV_NOS	9.487 [7.39, 12.17]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.116

During the follow-up period (1.1.1998 — 31.12.2019), 357 out of 1188 females with CMV_NOS died.

Males

Parameter	HR [95% CI]	p-value
CMV_NOS	7.015 [5.52, 8.92]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 461 out of 1368 males with CMV_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CMV_NOS.

N-year risk	Females	Males
1	0.788%	1.214%
5	5.163%	7.644%
10	11.688%	18.808%
15	22.762%	32.33%
20	36.887%	49.928%

Relationships between endpoints

↥

Index endpoint: CMV_NOS – Other/unspecified cytomegaloviral diseases

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other/unspecified cytomegaloviral diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints